Instil Bio, Inc.
TIL
$11.49
$0.716.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -29.99% | -21.98% | -14.17% | -9.00% | -15.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.98% | -22.79% | -28.26% | -33.78% | -45.12% |
| Operating Income | 4.98% | 22.79% | 28.26% | 33.78% | 45.12% |
| Income Before Tax | 0.12% | 29.33% | 36.72% | 52.50% | 61.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.12% | 29.33% | 36.72% | 52.50% | 61.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.12% | 29.33% | 36.72% | 52.50% | 61.85% |
| EBIT | 4.98% | 22.79% | 28.26% | 33.78% | 45.12% |
| EBITDA | 0.68% | 21.42% | 28.63% | 34.31% | 45.80% |
| EPS Basic | 1.40% | 29.72% | 36.86% | 52.54% | 61.87% |
| Normalized Basic EPS | 16.31% | 31.93% | 29.93% | 30.83% | 41.97% |
| EPS Diluted | 1.40% | 29.72% | 36.87% | 52.54% | 61.87% |
| Normalized Diluted EPS | 16.31% | 31.93% | 29.93% | 30.83% | 41.97% |
| Average Basic Shares Outstanding | 1.52% | 0.56% | 0.21% | 0.10% | 0.05% |
| Average Diluted Shares Outstanding | 1.52% | 0.56% | 0.21% | 0.10% | 0.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |